[Summary] Innovative drug research, development and commercialization in the fie
Harbour BioMed (stock code: 02142.HK) is a global biopharmaceutical company focused on the research, development and commercialization of innovative drugs in the fields of oncology and immunological diseases. The company is rapidly expanding its innovative drug pipeline through proprietary research, joint development and diversified cooperation models.
Harbour's proprietary antibody technology platform, Harbour Mice®, can generate fully human monoclonal antibodies in the forms of bispecific, double light chain (H2L2) and heavy chain-only (HCAb). The immune cell engagers (HBICE®) developed based on the HCAb antibody platform can achieve anti-tumor efficacy unattainable with traditional drug combination therapies. Harbour Mice®, HBICE® and the single B cell cloning and screening platform together form Harbour's next-generation innovative therapeutic antibody research and development engine.
Our Mission
Innovative drugs, platinum health
"Innovative drugs, platinum health" is the mission of Harbour BioMed. To achieve this mission, we carry out collaborations with internationally innovative efforts with top global academic institutions and biomedical companies, comprehensively advancing the research and development process of next-generation innovative therapies through independent innovation and diversified cooperation. Meanwhile, the company also licenses its technology to global biopharmaceutical companies and academic institutions, enhancing the industry's innovation capability and accelerating the delivery of more innovative therapies to patients.
What does Harbour BioMed (Shanghai) Co., Ltd. require? Who is Harbour BioMed hiring? Harbour BioMed recruitment: 其他类占比最多占47.2%，其次是电子/电器/通信技术类占23.6%. What education can get in at Harbour BioMed? 硕士占比最多占41.6%，其次是本科占34.8%. High education required at Harbour BioMed? 硕士占41.6%，博士占11.2%. Work experience required at Harbour BioMed? 1-3年占比最多占27%，其次是5-10年占24.7%. Where are the job locations at Harbour BioMed? 上海占比最多占52.8%，其次是苏州占34.8%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
